1. Home
  2. EVER vs RCUS Comparison

EVER vs RCUS Comparison

Compare EVER & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVER
  • RCUS
  • Stock Information
  • Founded
  • EVER 2008
  • RCUS 2015
  • Country
  • EVER United States
  • RCUS United States
  • Employees
  • EVER N/A
  • RCUS N/A
  • Industry
  • EVER Computer Software: Programming Data Processing
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVER Technology
  • RCUS Health Care
  • Exchange
  • EVER Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • EVER 929.6M
  • RCUS 906.4M
  • IPO Year
  • EVER 2018
  • RCUS 2018
  • Fundamental
  • Price
  • EVER $24.90
  • RCUS $9.40
  • Analyst Decision
  • EVER Strong Buy
  • RCUS Buy
  • Analyst Count
  • EVER 6
  • RCUS 8
  • Target Price
  • EVER $32.50
  • RCUS $20.86
  • AVG Volume (30 Days)
  • EVER 348.2K
  • RCUS 702.4K
  • Earning Date
  • EVER 08-04-2025
  • RCUS 08-07-2025
  • Dividend Yield
  • EVER N/A
  • RCUS N/A
  • EPS Growth
  • EVER N/A
  • RCUS N/A
  • EPS
  • EVER 1.03
  • RCUS N/A
  • Revenue
  • EVER $575,757,000.00
  • RCUS $141,000,000.00
  • Revenue This Year
  • EVER $32.07
  • RCUS N/A
  • Revenue Next Year
  • EVER $11.08
  • RCUS $28.73
  • P/E Ratio
  • EVER $23.50
  • RCUS N/A
  • Revenue Growth
  • EVER 113.43
  • RCUS N/A
  • 52 Week Low
  • EVER $16.63
  • RCUS $6.50
  • 52 Week High
  • EVER $30.03
  • RCUS $18.98
  • Technical
  • Relative Strength Index (RSI)
  • EVER 46.13
  • RCUS 49.82
  • Support Level
  • EVER $23.60
  • RCUS $9.14
  • Resistance Level
  • EVER $26.61
  • RCUS $9.93
  • Average True Range (ATR)
  • EVER 0.83
  • RCUS 0.47
  • MACD
  • EVER -0.10
  • RCUS -0.00
  • Stochastic Oscillator
  • EVER 28.62
  • RCUS 21.90

About EVER EverQuote Inc.

EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: